287 related articles for article (PubMed ID: 36341370)
1. Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
Li B
Front Immunol; 2022; 13():973881. PubMed ID: 36341370
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Kazemi MH; Sadri M; Najafi A; Rahimi A; Baghernejadan Z; Khorramdelazad H; Falak R
Front Immunol; 2022; 13():1018962. PubMed ID: 36389779
[TBL] [Abstract][Full Text] [Related]
3. Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.
Wu R; Forget MA; Chacon J; Bernatchez C; Haymaker C; Chen JQ; Hwu P; Radvanyi LG
Cancer J; 2012; 18(2):160-75. PubMed ID: 22453018
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment.
Gezgin G; Visser M; Ruano D; Santegoets SJ; de Miranda NFCC; van der Velden PA; Luyten GPM; van der Burg SH; Verdegaal EM; Jager MJ
Ophthalmol Sci; 2022 Jun; 2(2):100132. PubMed ID: 36249685
[TBL] [Abstract][Full Text] [Related]
5. Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.
Dudley ME; Gross CA; Somerville RP; Hong Y; Schaub NP; Rosati SF; White DE; Nathan D; Restifo NP; Steinberg SM; Wunderlich JR; Kammula US; Sherry RM; Yang JC; Phan GQ; Hughes MS; Laurencot CM; Rosenberg SA
J Clin Oncol; 2013 Jun; 31(17):2152-9. PubMed ID: 23650429
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
Radvanyi LG
Cancer J; 2015; 21(6):450-64. PubMed ID: 26588676
[TBL] [Abstract][Full Text] [Related]
7. Antigen-Presenting Intratumoral B Cells Affect CD4
Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
[TBL] [Abstract][Full Text] [Related]
8. Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
Googe PB; Theocharis S; Pergaris A; Li H; Yan Y; McKenna EF; Moschos SJ
Curr Probl Cancer; 2022 Jun; 46(3):100862. PubMed ID: 35398635
[TBL] [Abstract][Full Text] [Related]
9. Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges.
Zhao Y; Deng J; Rao S; Guo S; Shen J; Du F; Wu X; Chen Y; Li M; Chen M; Li X; Li W; Gu L; Sun Y; Zhang Z; Wen Q; Xiao Z; Li J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077696
[TBL] [Abstract][Full Text] [Related]
10. [Function of tumor infiltrating lymphocytes in solid tumors - a review].
Bai S; Yang X; Zhang N; Zhang F; Shen Z; Yang N; Zhang W; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2308-2325. PubMed ID: 31880138
[TBL] [Abstract][Full Text] [Related]
11. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
[TBL] [Abstract][Full Text] [Related]
12. Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection.
Balzeau J; Ravindran A; Wang X; Maisuria J; Lucchesi A; Yao H; Matsueda S
Cancer Immunol Immunother; 2023 Oct; 72(10):3377-3385. PubMed ID: 37468658
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions.
Granhøj JS; Witness Præst Jensen A; Presti M; Met Ö; Svane IM; Donia M
Expert Opin Biol Ther; 2022 May; 22(5):627-641. PubMed ID: 35414331
[TBL] [Abstract][Full Text] [Related]
14. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrating lymphocytes in malignant melanoma - allies or foes?
Zidlik V; Bezdekova M; Brychtova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):43-48. PubMed ID: 31649385
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma.
Vargas GM; Shafique N; Xu X; Karakousis G
Expert Rev Mol Diagn; 2024 Apr; 24(4):299-310. PubMed ID: 38314660
[TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy.
Lee N; Zakka LR; Mihm MC; Schatton T
Pathology; 2016 Feb; 48(2):177-87. PubMed ID: 27020390
[TBL] [Abstract][Full Text] [Related]
18. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Oble DA; Loewe R; Yu P; Mihm MC
Cancer Immun; 2009 Apr; 9():3. PubMed ID: 19338264
[TBL] [Abstract][Full Text] [Related]
19. Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function.
Ollé Hurtado M; Wolbert J; Fisher J; Flutter B; Stafford S; Barton J; Jain N; Barone G; Majani Y; Anderson J
PLoS One; 2019; 14(8):e0216373. PubMed ID: 31398192
[TBL] [Abstract][Full Text] [Related]
20.
Jiménez-Reinoso A; Nehme-Álvarez D; Domínguez-Alonso C; Álvarez-Vallina L
Front Oncol; 2020; 10():593848. PubMed ID: 33680923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]